
    ## Follow-Up with Bob

    Hi Bob,

    I came across this article that I thought would interest you: [Scientists unveil surprising human vs mouse differences in a major cancer immunotherapy target](https://www.sciencedaily.com/releases/2025/01/250103150915.htm)
    Summary: Much of our knowledge of the protein PD-1, a leading cancer treatment target, comes from studies in mice. In a comprehensive assessment of PD-1, researchers have found that PD-1 in mice is significantly weaker than the human version, providing new information on how cancer treatments are developed.

    Since you are an expert in Blockchain Development, Iâ€™d love to hear your thoughts. Let me know if you'd like to discuss this further.

    Best regards,  
    [Your Name]
    